Association between use of renin-angiotensin system inhibitors/angiotensin receptor neprilysin inhibitors and beta-blockers and outcome in real-world heart failure and mildly reduced ejection fraction
Event:
ESC Congress 2022
Topic:
Heart Failure with Mid-Range Ejection Fraction (HFmrEF)
Session:
HFpEF and HFmrEF: what’s new in treatment?